| 摘要 |
<p>The invention relates to the use of a pharmaceutically acceptable cholinesterase inhibitor or a pro-drug therefor in the manufacture of a medicament for combatting diseases associated with proteolytic enzyme activity, such as psoriasis, osteoarthritis, rheumatoid arthritis, Crohn's disease and Ulcerative Colitis.</p> |
